| Literature DB >> 35178335 |
Pedro Cortés1, Juan E Corral2, Shifa Umar3, Mohammad Bilal4, Bhaumik Brahmbhatt5, Francis A Farraye5, Paul T Kroner5.
Abstract
Background and study aims Splenic injury (SI) during colonoscopy is an underappreciated adverse event. Our aim was to examine the occurrence and outcomes of patients who developed SI after inpatient colonoscopy using a nationwide dataset. Patients and methods Retrospective, observational study using the National Inpatient Sample (NIS) between 2012 and 2018. All patients with ICD9/10CM procedural codes for colonoscopy with or without SI were included. The primary outcome was the association between SI and inpatient colonoscopy. Secondary outcomes were inpatient morbidity, mortality, resource utilization, splenectomy rates, hospital length of stay and total hospital costs and charges. Comparative analyses were performed between patients with and without SI. Multivariate regression analyses were utilized. Results A total of 2,258,040 of inpatient colonoscopies were included. Of these, 240 had associated SI and 25 patients required splenectomy (10.4 %). The incidence of colonoscopy-associated SI remained relatively stable between 2012 and 2018 (0.033 % versus 0.020 %, respectively). The mean age of patients with and without SI was 63.7 and 64.1 years, respectively. The occurrence of SI was calculated as 10.63 cases per 100,000 inpatient colonoscopies. Patients who had associated SI displayed significantly higher odds of inpatient mortality (aOR: 14.45) and ICU stay (aOR: 10.11) compared to those without SI. Conclusions Splenic injury confers significantly higher odds of inpatient mortality, and resource utilization. The incidence of SI related to colonoscopy remained stable during the study period. Although uncommon, SI should be considered when encountering patients with abdominal pain after colonoscopy. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Year: 2022 PMID: 35178335 PMCID: PMC8847061 DOI: 10.1055/a-1672-3733
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Cases and incidence of splenic injury over the study period, 2012–2018.
| Year | Splenic injury cases | Percentage relative to total colonoscopies | Overall incidence |
| 2012 | 40 | 0.033 % | 1 in 3,030 |
| 2013 | 20 | 0.017 % | 1 in 5,880 |
| 2014 | 25 | 0.022 % | 1 in 4,545 |
| 2015 | 35 | 0.041 % | 1 in 2,440 |
| 2016 | 60 | 0.023 % | 1 in 4,345 |
| 2017 | 30 | 0.012 % | 1 in 8,330 |
| 2018 | 50 | 0.020 % | 1 in 5,000 |
Baseline characteristics of patients undergoing colonoscopy that had associated splenic injury compared to those who did not.
| No splenic injury (n = 2,257,800) | Splenic injury (n = 240) | ||
| Mean age | 64.13 | 63.67 | 0.15 |
| Female gender | 52.71 % | 60.87 % | 0.27 |
| Race | 0.17 | ||
Caucasian | 68.09 % | 81.82 % | |
African American | 15.55 % | 6.82 % | |
Hispanic | 10.40 % | 6.82 % | |
Asian | 2.86 % | 2.27 % | |
Other | 3.10 % | 2.27 % | |
| Median income in zip code | 0.73 | ||
$ 1 – $ 37,999 | 28.85 % | 24.44 % | |
$ 38 K – 47,999 | 26.11 % | 33.33 % | |
$ 48 K – 63,999 | 24.25 % | 22.22 % | |
> $ 64,000 | 20.78 % | 20.00 % | |
| Charlson Comorbidity Index | 0.75 | ||
0 | 30.54 % | 23.91 % | |
1 | 22.02 % | 21.74 % | |
2 | 16.33 % | 17.39 % | |
3 or more | 31.11 % | 36.96 % | |
| Hospital region | 0.17 | ||
Northeast | 17.55 % | 17.39 % | |
Midwest | 23.89 % | 19.57 % | |
South | 37.90 % | 52.17 % | |
West | 20.66 % | 10.87 % | |
| Urban location | 91.80 % | 80.43 % | < 0.01 |
| Teaching hospital | 63.22 % | 60.87 % | 0.84 |
| Bed size | 0.73 | ||
Small | 17.59 % | 21.74 % | |
Medium | 29.51 % | 26.09 % | |
Large | 52.89 % | 52.17 % | |
Adjusted odds of outcomes in patients with splenic injury compared to those without splenic injury after inpatient colonoscopy.
| Outcome | Adjusted odds | 95 % confidence interval | |
| Inpatient mortality | 14.45 | 5.15–40.60 | < 0.01 |
| Shock | 6.13 | 2.48–15.10 | < 0.01 |
| ICU stay | 10.11 | 4.55–22.44 | < 0.01 |
| AKI | 1.26 | 0.51–3.16 | 0.62 |
ICU, intensive care unit; AKI, acute kidney injury.
Additional USD$ and length of stay in patients with splenic injury compared to those without splenic injury after colonoscopy.
| Outcome | Adjusted mean | 95 % confidence interval | |
| Additional costs |
$ 20,927
| $ 13,477, $ 28,377 | < 0.01 |
| Additional charges | $ 86,813 | $ 45,997, $ 127,629 | < 0.01 |
| Additional LOS (days) | 4.7 | 2.5,6.9 | < 0.01 |
LOS, length of stay.
The USD$ are adjusted for inflation using the Consumer Price Index.
Crude means comparing patients with splenic injury and without splenic injury.
| Outcome | No splenic injury | Splenic injury | |
| Costs | $13,030 | $34,872 | < 0.01 |
| Charges | $53,032 | $138,285 | < 0.01 |
| LOS (days) | 4.5 | 9.4 | < 0.01 |